These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10794812)

  • 41. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY.
    Balasubramaniam A; Ujhelyi M; Borchers M; Huang Y; Zhai W; Zhou Y; Johnson M; Sheriff S; Fischer JE
    J Med Chem; 1996 Mar; 39(5):1142-7. PubMed ID: 8676351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform.
    Rodriguez M; Audinot V; Dromaint S; Macia C; Lamamy V; Beauverger P; Rique H; Imbert J; Nicolas JP; Boutin JA; Galizzi JP
    Biochem J; 2003 Feb; 369(Pt 3):667-73. PubMed ID: 12398768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats.
    Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
    Eur J Pharmacol; 2009 May; 609(1-3):78-87. PubMed ID: 19285064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Feeding responses to several neuropeptide Y receptor agonists in the neonatal chick.
    Ando R; Kawakami SI; Bungo T; Ohgushi A; Takagi T; Denbow DM; Furuse M
    Eur J Pharmacol; 2001 Sep; 427(1):53-9. PubMed ID: 11553363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction.
    Dubinion JH; Mi Z; Zhu C; Gao L; Jackson EK
    Hypertension; 2006 Mar; 47(3):545-51. PubMed ID: 16365188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropeptide Y induced inhibition of noradrenaline release in rat hypothalamus: role of receptor subtype and nitric oxide.
    Bitran M; Tapia W; Eugenín E; Orio P; Boric MP
    Brain Res; 1999 Dec; 851(1-2):87-93. PubMed ID: 10642831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig.
    Lecklin A; Lundell I; Paananen L; Wikberg JE; Männistö PT; Larhammar D
    Br J Pharmacol; 2002 Apr; 135(8):2029-37. PubMed ID: 11959807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PYY preference is a common characteristic of neuropeptide Y receptors expressed in human, rat, and mouse gastrointestinal epithelia.
    Holliday ND; Pollock EL; Tough IR; Cox HM
    Can J Physiol Pharmacol; 2000 Feb; 78(2):126-33. PubMed ID: 10737675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuropeptide Y inhibits adenylyl cyclase activity in rabbit retina.
    Bruun A; Edvinsson L; Ehinger B
    Acta Ophthalmol (Copenh); 1994 Jun; 72(3):326-31. PubMed ID: 7526593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuropeptide Y: complete amino acid sequence of the brain peptide.
    Tatemoto K
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5485-9. PubMed ID: 6957876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Constitutive neuropeptide Y Y(4) receptor expression in human colonic adenocarcinoma cell lines.
    Cox HM; Tough IR; Zandvliet DW; Holliday ND
    Br J Pharmacol; 2001 Jan; 132(1):345-53. PubMed ID: 11156595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy.
    Michel MC; Gaida W; Beck-Sickinger AG; Wieland HA; Doods H; Dürr H; Jung G; Schnorrenberg G
    Mol Pharmacol; 1992 Oct; 42(4):642-8. PubMed ID: 1331755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels.
    Gardner A; Westfall TC; Macarthur H
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1109-17. PubMed ID: 15687374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists.
    Nunn C; Langenegger D; Hurth K; Schmidt K; Fehlmann D; Hoyer D
    Eur J Pharmacol; 2003 Apr; 465(3):211-8. PubMed ID: 12681432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The functional investigation of a human adenocarcinoma cell line, stably transfected with the neuropeptide Y Y1 receptor.
    Holliday ND; Cox HM
    Br J Pharmacol; 1996 Sep; 119(2):321-9. PubMed ID: 8886416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction of NPY compounds with the rat glucocorticoid-induced receptor (GIR) reveals similarity to the NPY-Y2 receptor.
    Sah R; Parker SL; Sheriff S; Eaton K; Balasubramaniam A; Sallee FR
    Peptides; 2007 Feb; 28(2):302-9. PubMed ID: 17240481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Apparent affinity and potency of BIBP3226, a non-peptide neuropeptide Y receptor antagonist, on purported neuropeptide Y Y1, Y2 and Y3 receptors.
    Jacques D; Cadieux A; Dumont Y; Quirion R
    Eur J Pharmacol; 1995 May; 278(1):R3-5. PubMed ID: 7664808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.